Calmann Melissa A, Marinus M G
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14174-9. doi: 10.1073/pnas.0406104101. Epub 2004 Sep 16.
Human cell lines and Escherichia coli dam mutants are sensitive to the cytotoxic action of the anticancer agent, cisplatin. Introduction of mutations disabling DNA mismatch repair into these cell lines renders them resistant to the action of this drug. We used RecA-mediated strand exchange between homologous phiX174 molecules, one that was platinated and the other that was unmodified, to show that strand transfer is decreased in a dose-dependent manner. Transfer was severely decreased at 10 adducts per molecule (5,386 bp) and abolished with 24 adducts. At low levels of adduction, addition of MutS to the reaction further decreases the rate and yield in a dose-dependent manner. MutL addition was without effect even in the presence of MutS. The results suggest that although mismatch repair is beneficial for mutation avoidance, its antirecombination activity on inappropriate substrates can be lethal to the cell.
人类细胞系和大肠杆菌dam突变体对抗癌药物顺铂的细胞毒性作用敏感。在这些细胞系中引入使DNA错配修复失活的突变会使它们对这种药物的作用产生抗性。我们利用RecA介导的同源phiX174分子间的链交换,其中一个分子被铂化而另一个未被修饰,来表明链转移以剂量依赖的方式减少。当每个分子有10个加合物(5386 bp)时,转移严重减少,而有24个加合物时则完全消除。在低水平加合时,向反应中添加MutS会以剂量依赖的方式进一步降低速率和产量。即使存在MutS,添加MutL也没有效果。结果表明,虽然错配修复有利于避免突变,但其在不适当底物上的抗重组活性可能对细胞是致命的。